| 000 | 04635nam a22003975i 4500 | ||
|---|---|---|---|
| 999 |
_c391285 _d391285 _x1 |
||
| 001 | 391285 | ||
| 003 | ES-MaUEC | ||
| 005 | 20240202101420.0 | ||
| 006 | a|||| o|||| 00| 0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 230603s2021 xxu| o |||| 0|eng d | ||
| 020 | _a9781071613276 | ||
| 024 | 7 |
_a10.1007/978-1-0716-1327-6 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aQH588 .S83 _b2021 EB |
|
| 245 | 0 | 0 |
_aStem Cells and Good Manufacturing Practices : _bMethods, Protocols, and Regulations _cedited by Kursad Turksen |
| 250 | _a2nd edition 2021 | ||
| 264 | 1 |
_aNew York, NY _bSpringer International Publising _c2021 |
|
| 300 |
_a1 recurso en línea (XII, 288 páginas) _b10 ilustraciones a color |
||
| 336 |
_atexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 347 |
_aarchivo de texto _bPDF |
||
| 490 | 0 |
_aMethods in Molecular Biology _x1940-6029 _v2286 |
|
| 505 | 0 | _aSwiss Fetal Transplantation Program and Non-Enzymatically Isolated Primary Progenitor Cell Types for Regenerative Medicine -- GMP Tiered Cell Banking of Non-Enzymatically Isolated Dermal Progenitor Fibroblasts for Allogenic Regenerative Medicine -- Progenitor Biological Bandages: An Authentic Swiss Tool for Safe Therapeutic Management of Burns, Ulcers, and Donor Site Grafts -- Validation of the Media Fill Method for Solid Tissue Processing in Good Manufacturing Practice-Compliant Cell Production -- The Isolation, Culturing, Cryopreservation, and the Preparation as a Final Cellular Product of the Umbilical Cord-Derived Mesenchymal Stem Cells Under Good Manufacturing Practices Conditions -- The Isolation, Culture, Cryopreservation, and the Preparation as a Final Cellular Product of the Skin-Derived Fibroblasts Under Good Manufacturing Practice Conditions -- The Isolation and Manufacture of GMP-Grade Bone Marrow Stromal Cells from Bone Specimens -- Scalable Manufacturing of Human Hematopoietic Stem/Progenitor Cells Exploiting a Co-Culture Platform with Mesenchymal Stromal Cells -- GMP-Compatible, Xeno-Free Culture of Human Induced Mesenchymal Stem Cells -- GMP-Grade Methods for Cardiac Progenitor Cells: Cell Bank Production and Quality Control -- Suspension Culture of Human Induced Pluripotent Stem Cells in Single-Use Vertical-WheelTM Bioreactors Using Aggregate and Microcarrier Culture Systems -- Addressing Manufacturing Challenges for Commercialization of iPSC-Based Therapies -- Standard Operating Procedure for the Good Manufacturing Practice-Compliant Production of Human Endometrial Stem Cells for Multiple Sclerosis -- GMP-Compliant Production of Human Placenta-Derived Mesenchymal Stem Cells -- GMP-Compliant Human Schwann Cells Manufacturing for Clinical Application -- GMP-Compliant Adenoviral Vectors for Gene Therapy -- Use of Multipotent Mesenchymal Stromal Cells, Fibrin, and Scaffolds in ihe Production of Clinical Grade Bone Tissue Engineering Products -- Quality Management Systems (QMSs) of Human Tissue- and Cell-Based Product Manufacturing Facilities. | |
| 520 | _aThis detailed book explores the utilization and delivery of stem cells for therapeutic purposes in patients in the clinic and the tightly controlled Good Manufacturing Practices (GMP) that make these powerful techniques possible. Fully updated and expanded from the first edition, this collection features a new set of protocols to arm stem cell biologists with protocols that are currently being used in a number of well-established facilities around the world. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and up to date, Stem Cells and Good Manufacturing Practices: Methods, Protocols, and Regulations, Second Edition serves as an ideal guide for researchers aiming to drive continued improvements to GMP and accelerate new stem cell treatments for patients in need. | ||
| 988 | _aSpringer_Protocols_2021 | ||
| 650 | 7 |
_2embne _9160528 _aCélulas madre |
|
| 776 | 0 | 8 |
_iPrinted edition: _z9781071613269 |
| 776 | 0 | 8 |
_iPrinted edition: _z9781071613283 |
| 776 | 0 | 8 |
_iPrinted edition: _z9781071613290 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-1-0716-1327-6 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_b06/2023 _dz _eIG _zSI |
||